Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans-Reference-Cited by-同舟云学术

Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans

Published:2010-05 Issue:5 Volume:59 Page:734-741
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Bordicchia Marica,Battistoni Ilaria,Mancinelli Lucia,Giannini Elena,Refi Giada,Minardi Daniele,Muzzonigro Giovanni,Mazzucchelli Roberta,Montironi Rodolfo,Piscitelli Fabiana,Petrosino Stefania,Dessì-Fulgheri Paolo,Rappelli Alessandro,Di Marzo Vincenzo,Sarzani Riccardo

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

2. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome and hypertension: an integrated view in humans;Sarzani;J Hypertens,2008

3. Obesity and target organ damage: the kidney;de Jong;Int J Obes Relat Metab Disord,2002

4. The influence of obesity on the development and survival outcomes of chronic kidney disease;Wiggins;Adv Chronic Kidney Dis,2005

5. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis;Cota;J Clin Invest,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease;Handbook of Experimental Pharmacology;2024

2. Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight;Obesity;2023-06-27

3. Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes;Journal of Controlled Release;2023-01

4. Understanding the possible role of endocannabinoid system in obesity;Prostaglandins & Other Lipid Mediators;2021-02

5. The endocannabinoid system in the adipose organ;Reviews in Endocrine and Metabolic Disorders;2021-01-02